Alterity Therapeutics Limited
ATH
Rank in Stocks
#26118
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Share Price
$0.1904269
Market Cap
$41.61M
Change (1 day)
-3.57%
Change (1 year)
-45.59%
Country
AU
Trade Alterity Therapeutics Limited (ATH)
Category
Healthcare
Stock split history for Alterity Therapeutics Limited (ATH)
Alterity Therapeutics Limited stock (symbol: ATH) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One ATH share bought prior to Oct 20, 2026 would equal to 0 ATH shares today.
The most recent stock split occurred on Oct 20, 2026.
One ATH share bought prior to Oct 20, 2026 would equal to 0 ATH shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
